معرفی
Vicky Caveliers is a Researcher at Ghent University's Department of Molecular Imaging and Therapy, focusing on radiopharmaceutical development for PET and radionuclide therapy using camelid single-domain antibodies (nanobodies). Her work emphasizes automated radiolabeling, GMP manufacturing, and clinical translation of imaging probes. She leads projects like VYPER (VyPAL enzyme-mediated radiotheranostics) and RAPTOR (bioreactor systems for protein production). Collaborations span Belgium, Europe, and international institutions.
Education background inferred from career trajectory includes advanced training in nuclear medicine, radiopharmacy, and molecular imaging. Research interests center on optimizing radiopharmaceutical pipelines, from preclinical validation to clinical trials, with a focus on HER2-targeted therapies and immune checkpoint imaging (e.g., TIGIT).
Key achievements include 5441 citations and a h-index of 42, reflecting impactful contributions to theranostic imaging. Awards include the 2020 ESMI Best Oral Presentation Award. Active in academic leadership, she supervises 33 student theses and contributes to 28 funded projects. Her lab's innovations include automated radiosynthesis systems and novel radiotracer formulations for clinical use.
Grants include FWOAL1154 (VyPAL theranostics), OZR4288 (RAPTOR bioreactor systems), and SRP95 (peptide-based imaging agents). Labs focus on nanobody engineering, radiochemistry, and translational nuclear medicine. Future work targets expanding clinical applications of nanobody-based PET tracers and improving automated production workflows.
